Tajwan - Ċiniż - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

台灣費森尤斯卡比股份有限公司 臺北市大安區仁愛路3段30號5樓、32號5樓 (12980985) - palonosetron (as hydrochloride) - 注射劑 - palonosetron (as hydrochloride) (5622001720) (0.056mg)mg - palonosetron - 成人：預防化學療法引起之噁心和嘔吐。●中度致嘔性癌症化學療法--預防起始及反覆療程引起之急性及延遲性噁心及嘔吐。●高度致嘔性癌症化學療法--預防起始及反覆療程引起之急性噁心和嘔吐。兒童與青少年(1個月大至17歲)●預防高度致嘔吐癌症化學療法引起之急性噁心和嘔吐。●預防中度致嘔吐癌症化學療法引起之噁心和嘔吐。

Tajwan - Ċiniż - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

台灣費森尤斯卡比股份有限公司 臺北市大安區仁愛路3段30號5樓、32號5樓 (12980985) - moxifloxacin hydrochloride - 靜脈點滴注射劑 - moxifloxacin hydrochloride (0812700910) (corresponding to 400mg moxifloxacin)mg - moxifloxacin - 用於治療成人(十八歲以上)感受性細菌引起的感染症，包括：上呼吸道及下呼吸道感染(急性鼻竇炎、慢性支氣管的急性惡化、社區性肺炎)，皮膚和軟組織的感染，複雜腹腔內感染(包括多種細菌感染症)。

Tajwan - Ċiniż - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

台灣費森尤斯卡比股份有限公司 臺北市大安區仁愛路3段30號5樓、32號5樓 (12980985) - sodium glycerophosphate hydrated - 注射液劑 - sodium glycerophosphate hydrated (9200008510) (corresp. to sodium glycerophosphate......216 mg)mg - sodium glycerophosphate - 使用於接受靜脈營養補充的病人，以滿足磷酸根離子的需求。

Tajwan - Ċiniż - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

瑞士商艾伯維藥品有限公司台灣分公司 台北市中山區民生東路三段49號及51號15樓 (53653958) - levodopa;;carbidopa monohydrate - 腸凝膠劑 - levodopa (1208002900) mg; carbidopa monohydrate (2408000420) mg - levodopa and decarboxylase inhibitor - 適合在晚期巴金森(advanced parkinson's diease)患者中，用以治療動作波動現象(motor fluctuation)。

Tajwan - Ċiniż - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

輝瑞大藥廠股份有限公司 台北市信義區松仁路100號42、43樓 (37199708) - linezolid - 注射劑 - linezolid (9200042000) 2mg - linezolid - 「治療由下列感受性菌株感染的患者： vancomycin 抗藥性的enterococcus faecium感染，包括併發菌血症的病例。醫院感染的肺炎，由 staphylococcus aureus（對 methicillin 有感受性和對methicillin有抗藥性的菌株）或streptococcus pneumoniae (對penicillin有感受性的菌株)所引起。複雜性皮膚和皮膚構造咸染，包括糖尿病足感染，無併發骨髓炎，由staphylococcus aureus（對 methicillin 有感受性和對methicillin有抗藥性的菌株）、 streptococcus pyogenes 或streptococcus agalactiae所引起。非複雜性皮膚和皮膚構造感染，由staphylococcus aureus (僅限於對 methicillin 有感受性的菌株）或streptococcus pyogenes 所引起。社區感染的肺炎，由streptococcus pneumoniae (僅限於對penicillin有感受性的菌秣），包括併發菌血症的病例，或staphylococcus aureus（僅限於對methicillin有感受性的菌株）所引起」。

Tajwan - Ċiniż - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

台灣費森尤斯卡比股份有限公司 臺北市大安區仁愛路3段30號5樓、32號5樓 (12980985) - pemetrexed disodium heptahydrate - 凍晶注射劑 - pemetrexed disodium heptahydrate (1004002410) pemetrexed (as pemetrexed disodium) (pemetrexed disodium is formed in situ from pemetrexed diacid)mg - pemetrexed - 1.併用cisplatin是治療局部晚期或轉移性非小細胞肺癌（顯著鱗狀細胞組織型除外）之第一線化療用藥。2.pemetrexed單一藥物是局部晚期或轉移性非小細胞肺癌（顯著鱗狀細胞組織型除外）病人接受4個週期含鉑藥物的第一線化療後疾病並未惡化之維持療法。3.單一藥物是治療局部晚期或轉移性非小細胞肺癌（顯著鱗狀細胞組織型除外）之第二線治療用藥。4.與cisplatin併用於治療惡性肋膜間質細胞瘤。

Tajwan - Ċiniż - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

台灣費森尤斯卡比股份有限公司 臺北市大安區仁愛路3段30號5樓、32號5樓 (12980985) - pemetrexed disodium heptahydrate - 凍晶注射劑 - pemetrexed disodium heptahydrate (1004002410) pemetrexed (as pemetrexed disodium) (pemetrexed disodium is formed in situ from pemetrexed diacid)mg - pemetrexed - 1.併用cisplatin是治療局部晚期或轉移性非小細胞肺癌（顯著鱗狀細胞組織型除外）之第一線化療用藥。2.pemetrexed單一藥物是局部晚期或轉移性非小細胞肺癌（顯著鱗狀細胞組織型除外）病人接受4個週期含鉑藥物的第一線化療後疾病並未惡化之維持療法。3.單一藥物是治療局部晚期或轉移性非小細胞肺癌（顯著鱗狀細胞組織型除外）之第二線治療用藥。4.與cisplatin併用於治療惡性肋膜間質細胞瘤。

Tajwan - Ċiniż - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

台灣費森尤斯卡比股份有限公司 臺北市大安區仁愛路3段30號5樓、32號5樓 (12980985) - tyrosine;;magnesium sulfate;;triglycerides medium chain;;proline;;potassium chloride;;fish-oil rich in omega-3 acids;;glycine (eq to aminoacetic acid)(eq to glycocoll);;calcium chloride (dihydrate);;isoleucine;;phenylalanine;;threonine;;taurine (eq to aminoethyl sulfonic acid );;lysine (acetate);;zinc sulfate;;leucine;;serine;;olive oil;;sodium glycerophosphate;;soybean oil ( eq to soya bean oil);;arginine;;tryptophan;;valine;;methionine;;sodium acetate (trihydrate);;glucose (monohydrate);;alanine;;histidine;;fish-oil rich in omega-3 acids;;olive oil;;soybean oil ( eq to soya bean oil);;triglycerides medium chain;;glucose (monohydrate);;lysine (acetate);;alanine;;valine;;sodium glycerophosphate;;taurine (eq to aminoethyl sulfonic acid );;potassium chloride;;proline;;histidine;;phenylalanine;;arginine;;tryptophan;;methionine;;serine;;magnesium sulfate;;zinc sulfate;;leucine;;glycine (eq to aminoacetic acid)(eq to glycocoll);;threonine;;sodium acetate (trihydrate);;calcium chloride (dihydrate);;tyrosine;;isoleucine - 注射劑 - glucose (monohydrate) (4020009760) (462)mg; soybean oil ( eq to soya bean oil) (4020001600) refinedmg; fish-oil rich in omega-3 acids (4020003620) mg; triglycerides medium chain (5640001102) mg; olive oil (9600021200) refinedmg; sodium acetate (trihydrate) (4008007670) (5.62)mg; potassium chloride (4012001800) (e508)mg; calcium chloride (dihydrate) (4012007350) (0.74)mg; alanine (4020100200) mg; arginine (4020100300) mg; histidine (4020100900) mg; isoleucine (4020101000) mg; leucine (4020101200) mg; methionine (4020101500) mg; phenylalanine (4020101700) mg; proline (4020101800) mg; serine (4020101900) mg; threonine (4020102000) mg; tryptophan (4020102100) mg; tyrosine (4020102200) mg; valine (4020102300) mg; glycine (eq to aminoacetic acid)(eq to glycocoll) (4020102400) mg; lysine (acetate) (4020191320) (9.3)mg; magnesium sulfate (5612001500) (7h2o 2.47)mg; taurine (eq to aminoethyl sulfonic acid ) (9200000920) mg; sodium glycerophosphate (9200008500) mg; zinc sulfate (9200010600) (7h2o 23)mcg; sodium acetate (trihydrate) (4008007670) mg; potassium chloride (4012001800) mg; calcium chloride (dihydrate) (4012007350) mg; soybean oil ( eq to soya bean oil) (4020001600) refinedmg; fish-oil rich in omega-3 acids (4020003620) mg; glucose (monohydrate) (4020009760) mg; alanine (4020100200) mg; arginine (4020100300) mg; histidine (4020100900) mg; isoleucine (4020101000) mg; leucine (4020101200) mg; methionine (4020101500) mg; phenylalanine (4020101700) mg; proline (4020101800) mg; serine (4020101900) mg; threonine (4020102000) mg; tryptophan (4020102100) mg; tyrosine (4020102200) mg; valine (4020102300) mg; glycine (eq to aminoacetic acid)(eq to glycocoll) (4020102400) mg; lysine (acetate) (4020191320) mg; magnesium sulfate (5612001500) (heptahydroate)mg; triglycerides medium chain (5640001102) mg; taurine (eq to aminoethyl sulfonic acid ) (9200000920) mg; sodium glycerophosphate (9200008500) (hydrate)mg; zinc sulfate (9200010600) a9heptahydrate0mg; olive oil (9600021200) refinedmg - combinations - 靜脈營養輸注，適用於無法由口腔進食或經腸道獲取足夠營養，或禁止由口腔及腸道進食之成年患者及2歲以上兒童。

Tajwan - Ċiniż - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

台灣費森尤斯卡比股份有限公司 臺北市大安區仁愛路3段30號5樓、32號5樓 (12980985) - triglycerides medium chain;;soybean oil ( eq to soya bean oil);;fish-oil rich in omega-3 acids;;olive oil;;l-valine;;l-threonine;;l-lysine acetate;;glycine (eq to aminoacetic acid)(eq to glycocoll);;l-tryptophan;;l-phenylalanine;;l-histidine;;l-serine;;taurine (eq to aminoethyl sulfonic acid );;l-methionine;;l-leucine;;l-proline;;l-tyrosine;;l-isoleucine;;l-alanine;;l-arginine;;glucose monohydrate - 注射劑 - l-alanine (4020100202) mg; l-arginine (4020100305) mg; l-histidine (4020100902) mg; l-isoleucine (4020101002) mg; l-leucine (4020101202) mg; l-lysine acetate (4020101322) corresponding to l-lysine 6.6mgmg; l-methionine (4020101502) mg; l-phenylalanine (4020101702) mg; l-proline (4020101802) mg; l-serine (4020101902) mg; l-threonine (4020102002) mg; l-tryptophan (4020102102) mg; l-tyrosine (4020102202) mg; l-valine (4020102302) mg; glycine (eq to aminoacetic acid)(eq to glycocoll) (4020102400) mg; taurine (eq to aminoethyl sulfonic acid ) (9200000920) mg; glucose monohydrate (4020000760) corresponding to glucose (anhydrous) 420mgmg; soybean oil ( eq to soya bean oil) (4020001600) soya-bean oil, refinedmg; fish-oil rich in omega-3 acids (4020003620) mg; triglycerides medium chain (5640001102) mg; olive oil (9600021200) olive oil, refinedmg - combinations - 無法給予口服/腸道營養或口服/腸道營養不足或禁用時，適用於成人及2歲以上兒童病患的靜脈營養劑。

Tajwan - Ċiniż - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

台灣費森尤斯卡比股份有限公司 臺北市大安區仁愛路3段30號5樓、32號5樓 (12980985) - gemcitabine hydrochloride;;gemcitabine hydrochloride - 凍晶注射劑 - gemcitabine hydrochloride (1010000610) (eq. to gemcitabine 200mg)mg; gemcitabine hydrochloride (1010000610) (eq. to gemcitabine 1g)mg - gemcitabine - 非小細胞肺癌、胰臟癌、膀胱癌。gemcitabine與paclitaxel併用，可使用於曾經使用過anthracycline之局部復發且無法手術切除或轉移性之乳癌病患。用於曾經使用含鉑類藥物(platinum-based)治療後復發且間隔至少6個月之卵巢癌，作為第二線治療。膽道癌。